Insight
High Resolution Mass Spectrometry and Nano-Flow Liquid Chromatography for Critical Reagent-Free Quantitation of Intact Peptides
This presentation covers:
- Specificity challenges with immunoassay
- Sensitivity challenges with both LBA and LCMS
- Nano-flow LC for ultimate sensitivity
- SEC allows robustness of downstream microfluidics and narrow-bore columns
Download presentation slides or watch presentation with narration.
Related Insights

ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.

Hybrid Assays for Protein Bioanalysis
Assays and Why Are They Essential for Protein Bioanalysis?

Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
High Throughput ADME Testing
Minimizing turnaround time for ADME assays
ADME Services
Accelerating your drug discovery, preclinical and clinical programs with ADME services
Assay Development for Large-Scale Clinical Studies
Bioanalytical expertise to support large-scale, international studies
Early Hit-to-Lead ADME Screening Bundle
Bundled Screening Assays to Accelerate Candidate Selection in Drug Discovery
High Throughput ADME Screening Services
Capabilities that accelerate preclinical studies
IND-Enabling Bundle of In Vitro Assays to Assess Drug-Drug Interaction Risk
DDI Fact Sheet